These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 23601898)

  • 1. Combination of vessel-targeting agents and fractionated radiation therapy: the role of the SDF-1/CXCR4 pathway.
    Chen FH; Fu SY; Yang YC; Wang CC; Chiang CS; Hong JH
    Int J Radiat Oncol Biol Phys; 2013 Jul; 86(4):777-84. PubMed ID: 23601898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vasculatures in tumors growing from preirradiated tissues: formed by vasculogenesis and resistant to radiation and antiangiogenic therapy.
    Chen FH; Chiang CS; Wang CC; Fu SY; Tsai CS; Jung SM; Wen CJ; Lee CC; Hong JH
    Int J Radiat Oncol Biol Phys; 2011 Aug; 80(5):1512-21. PubMed ID: 21621344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The EGFR inhibitor gefitinib suppresses recruitment of pericytes and bone marrow-derived perivascular cells into tumor vessels.
    Iivanainen E; Lauttia S; Zhang N; Tvorogov D; Kulmala J; Grenman R; Salven P; Elenius K
    Microvasc Res; 2009 Dec; 78(3):278-85. PubMed ID: 19596357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of vasculogenesis, but not angiogenesis, prevents the recurrence of glioblastoma after irradiation in mice.
    Kioi M; Vogel H; Schultz G; Hoffman RM; Harsh GR; Brown JM
    J Clin Invest; 2010 Mar; 120(3):694-705. PubMed ID: 20179352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blocking SDF-1α/CXCR4 downregulates PDGF-B and inhibits bone marrow-derived pericyte differentiation and tumor vascular expansion in Ewing tumors.
    Hamdan R; Zhou Z; Kleinerman ES
    Mol Cancer Ther; 2014 Feb; 13(2):483-91. PubMed ID: 24282276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor stromal-derived factor-1 recruits vascular progenitors to mitotic neovasculature, where microenvironment influences their differentiated phenotypes.
    Aghi M; Cohen KS; Klein RJ; Scadden DT; Chiocca EA
    Cancer Res; 2006 Sep; 66(18):9054-64. PubMed ID: 16982747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antitumor activity of ZD6126, a novel vascular-targeting agent, is enhanced when combined with ZD1839, an epidermal growth factor receptor tyrosine kinase inhibitor, and potentiates the effects of radiation in a human non-small cell lung cancer xenograft model.
    Raben D; Bianco C; Damiano V; Bianco R; Melisi D; Mignogna C; D'Armiento FP; Cionini L; Bianco AR; Tortora G; Ciardiello F; Bunn P
    Mol Cancer Ther; 2004 Aug; 3(8):977-83. PubMed ID: 15299080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CXCR4-mediated bone marrow progenitor cell maintenance and mobilization are modulated by c-kit activity.
    Cheng M; Zhou J; Wu M; Boriboun C; Thorne T; Liu T; Xiang Z; Zeng Q; Tanaka T; Tang YL; Kishore R; Tomasson MH; Miller RJ; Losordo DW; Qin G
    Circ Res; 2010 Oct; 107(9):1083-93. PubMed ID: 20847314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stromal cell-derived factor-1 stimulates vasculogenesis and enhances Ewing's sarcoma tumor growth in the absence of vascular endothelial growth factor.
    Reddy K; Zhou Z; Jia SF; Lee TH; Morales-Arias J; Cao Y; Kleinerman ES
    Int J Cancer; 2008 Aug; 123(4):831-7. PubMed ID: 18537159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting SDF-1 in multiple myeloma tumor microenvironment.
    Bouyssou JM; Ghobrial IM; Roccaro AM
    Cancer Lett; 2016 Sep; 380(1):315-8. PubMed ID: 26655999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PDGFR-β inhibitor slows tumor growth but increases metastasis in combined radiotherapy and Endostar therapy.
    Yin L; He J; Xue J; Na F; Tong R; Wang J; Gao H; Tang F; Mo X; Deng L; Lu Y
    Biomed Pharmacother; 2018 Mar; 99():615-621. PubMed ID: 29653486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mesenchymal stem cells generate pericytes to promote tumor recurrence via vasculogenesis after stereotactic body radiation therapy.
    Wang HH; Cui YL; Zaorsky NG; Lan J; Deng L; Zeng XL; Wu ZQ; Tao Z; Guo WH; Wang QX; Zhao LJ; Yuan ZY; Lu Y; Wang P; Meng MB
    Cancer Lett; 2016 Jun; 375(2):349-359. PubMed ID: 26996301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delivery of siRNA Using CXCR4-targeted Nanoparticles Modulates Tumor Microenvironment and Achieves a Potent Antitumor Response in Liver Cancer.
    Liu JY; Chiang T; Liu CH; Chern GG; Lin TT; Gao DY; Chen Y
    Mol Ther; 2015 Nov; 23(11):1772-1782. PubMed ID: 26278330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A critical role of Src family kinase in SDF-1/CXCR4-mediated bone-marrow progenitor cell recruitment to the ischemic heart.
    Cheng M; Huang K; Zhou J; Yan D; Tang YL; Zhao TC; Miller RJ; Kishore R; Losordo DW; Qin G
    J Mol Cell Cardiol; 2015 Apr; 81():49-53. PubMed ID: 25655934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dissecting the role of the CXCL12/CXCR4 axis in acute myeloid leukaemia.
    Ladikou EE; Chevassut T; Pepper CJ; Pepper AG
    Br J Haematol; 2020 Jun; 189(5):815-825. PubMed ID: 32135579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The chemokine CXCL12 and its receptor CXCR4 promote glioma stem cell-mediated VEGF production and tumour angiogenesis via PI3K/AKT signalling.
    Ping YF; Yao XH; Jiang JY; Zhao LT; Yu SC; Jiang T; Lin MC; Chen JH; Wang B; Zhang R; Cui YH; Qian C; Wang Jm; Bian XW
    J Pathol; 2011 Jul; 224(3):344-54. PubMed ID: 21618540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SDF-1/CXCR4 signalling is involved in blood vessel growth and remodelling by intussusception.
    Dimova I; Karthik S; Makanya A; Hlushchuk R; Semela D; Volarevic V; Djonov V
    J Cell Mol Med; 2019 Jun; 23(6):3916-3926. PubMed ID: 30950188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting CXCL12/CXCR4 and myeloid cells to improve the therapeutic ratio in patient-derived cervical cancer models treated with radio-chemotherapy.
    Lecavalier-Barsoum M; Chaudary N; Han K; Pintilie M; Hill RP; Milosevic M
    Br J Cancer; 2019 Jul; 121(3):249-256. PubMed ID: 31239542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CXCR4 inhibitors: tumor vasculature and therapeutic challenges.
    de Nigris F; Schiano C; Infante T; Napoli C
    Recent Pat Anticancer Drug Discov; 2012 Sep; 7(3):251-64. PubMed ID: 22376154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemokine (C-X-C motif) receptor 4 blockade by AMD3100 inhibits experimental abdominal aortic aneurysm expansion through anti-inflammatory effects.
    Michineau S; Franck G; Wagner-Ballon O; Dai J; Allaire E; Gervais M
    Arterioscler Thromb Vasc Biol; 2014 Aug; 34(8):1747-55. PubMed ID: 24876351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.